C
Market Data
$1.65−$0.62 (−27.31%)
CMMB · Last trade
Prev Close
$2.27
Range (29d)
$1.36 – $2.77
Recent Filings
- 6-K809.6 KBChemomab Therapeutics Ltd.Jul 8, 7:34 AM ET·0001178913-26-003442
- 6-K12.9 KBChemomab Therapeutics Ltd.Jun 2, 4:03 PM ET·0001178913-26-003058
- 6-K264.9 KBChemomab Therapeutics Ltd.May 14, 8:00 AM ET·0001178913-26-002672
- 6-K11.0 KBChemomab Therapeutics Ltd.May 6, 5:03 PM ET·0001178913-26-002423
- 6-K11.1 KBChemomab Therapeutics Ltd.Apr 28, 4:06 PM ET·0001178913-26-002274
- 6-K1.0 MBChemomab Therapeutics Ltd.Mar 20, 4:05 PM ET·0001178913-26-001571
- 6-K362.0 KBChemomab Therapeutics Ltd.Mar 19, 8:05 AM ET·0001178913-26-001550
- 6-K214.2 KBChemomab Therapeutics Ltd.Nov 21, 6:15 AM ET·0001178913-25-003932
- 6-K11.2 KBChemomab Therapeutics Ltd.Aug 22, 4:05 PM ET·0001178913-25-003015
- 6-K3.3 MBChemomab Therapeutics Ltd.Aug 14, 8:01 AM ET·0001178913-25-002894
Insiders
10- Access Industries Holdings LLC10% Owner
- ACCESS INDUSTRIES, LLCAffiliate of 10% Owner
- ACCESS INDUSTRIES MANAGEMENT, LLCAffiliate of 10% Owner
- Aharon ArnonChief Medical Officer
- Alon RuthDirector
- Blavatnik LenAffiliate of 10% Owner
- Burgin JonathanSee Remarks
- Cohen Neil HarrisDirector
- Daly Sean TVP, Clinical Operations
- Darvish NissimDirector
Tickers
Addresses
business
KIRYAT ATIDIM, BUILDING 7
TEL AVIV
mailing
KIRYAT ATIDIM, BUILDING 7
TEL AVIV
Former Names
- Anchiano Therapeutics Ltd.2021-03-17
- BioCancell Ltd.2015-11-03